Welcome to Peptide Card of AntiTbPdb
| This page displays user query in tabular form. |
KWKSFLKTFKSAKKTVLHTLLKAISS details |
| Primary information | |
|---|---|
| ID | antitb_1307, |
| Name | 20858205 |
| N-Terminal modification | D-(V13K,A20L) D2 |
| C-Terminal Modification | KWKSFLKTFKSAKKTVLHTLLKAISS |
| Chemical Modification | Acetylation |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 26 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Cell Line | MIC = 83.7 μg/mL |
| Inhibition Concentration | In vitro |
| Sequence | 2011 |
| Cytotoxicity | Human erythrocyte |
| In vivo Model | NA |
| Lethal Dose | HC50 = 83 μg/mL |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
| Tertiary Structure (Technique) | Not Predicted), |
| Primary information | |
|---|---|
| ID | antitb_1312, |
| Name | 20858205 |
| N-Terminal modification | D-(V13K,A20L) D2 |
| C-Terminal Modification | KWKSFLKTFKSAKKTVLHTLLKAISS |
| Chemical Modification | Acetylation |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 26 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv multidrug resistant strain vertulo |
| Cell Line | MIC = 72 μg/mL |
| Inhibition Concentration | In vitro |
| Sequence | 2011 |
| Cytotoxicity | Human erythrocyte |
| In vivo Model | NA |
| Lethal Dose | HC50 = 12 μg/mL |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
| Tertiary Structure (Technique) | Not Predicted), |